Cefotaxime 250mg Injection

Cefotaxime 250mg is an injectable third-generation cephalosporin antibiotic used for susceptible bacterial infections. It may be used for serious infections involving the lungs, urinary tract, abdomen, skin and soft tissue, bones and joints, blood, meninges, or reproductive tract when cefotaxime is appropriate for the organism and clinical plan.
Cefotaxime 250mg should be administered by a qualified healthcare professional by IV injection, IV infusion, or deep IM injection as prescribed. The reconstituted product should be prepared, diluted, and used according to the product label and local aseptic procedure. Do not self-inject or change the schedule without clinical supervision.
Cefotaxime binds bacterial penicillin-binding proteins and blocks cell-wall synthesis. Susceptible bacteria lose cell-wall strength and die.
Possible side effects include injection-site pain or inflammation, diarrhoea, nausea, vomiting, rash, itching, fever, abnormal liver-enzyme results, low blood-cell counts, and, rarely, severe allergic reaction, seizures, or antibiotic-associated colitis.
Use only for a proven or strongly suspected bacterial infection or a valid prophylaxis indication. Seek urgent medical help for breathing difficulty, facial swelling, widespread rash, severe watery or bloody diarrhoea, seizures, or signs of a serious allergic reaction. Kidney function and blood counts may need monitoring during prolonged or high-dose treatment.
Cefotaxime 250mg provides parenteral cefotaxime therapy when an injectable cephalosporin is needed for susceptible bacteria. The 250mg strength can help clinicians match vial strength to the prescribed dose, dilution plan, and stock requirement.
Cefotaxime 250mg is used for susceptible bacterial infections when a clinician chooses cefotaxime injection based on infection site, severity, and likely or confirmed organism.
Cefotaxime 250mg is given by IV or IM administration by a healthcare professional after proper reconstitution or dilution. The exact schedule depends on the infection and patient factors.
No. Cefotaxime is an antibiotic for bacterial infections and does not treat viral infections such as colds or flu.
Tell your doctor about cephalosporin or penicillin allergy, kidney disease, previous severe antibiotic-associated diarrhoea, pregnancy, breastfeeding, and current medicines.
The prescribed course should be completed unless the clinician changes it. Stopping early may allow infection to return and can contribute to antibiotic resistance.
Seek urgent help for breathing difficulty, swelling, severe rash, seizures, severe diarrhoea, or signs of a serious allergic reaction.
Cefotaxime: third-generation cephalosporin antibiotic. IV: intravenous administration. IM: intramuscular administration. Susceptible bacteria: bacteria expected to respond to the antibiotic., AR: Cefotaxime حقن, FR: Cefotaxime, PT: Cefotaxime injeção, ES: Cefotaxime inyección, RU: Cefotaxime инъекция, ID: Cefotaxime injeksi, VI: Cefotaxime thuốc tiêm, MS: Cefotaxime suntikan, TL: Cefotaxime iniksyon, ZH-SG: Cefotaxime 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Cefotaxime 250mg Injection under Antibiotics. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Cefotaxime 250mg Injection